Siga Technologies (SIGA) Net Cash Flow (2010 - 2025)
Siga Technologies' (SIGA) quarterly Net Cash Flow came in at -$10.5 million in Q3 2025, down 36.82% on a YoY basis from -$16.6 million in Q3 2024, and down 152.04% quarter-over-quarter from $20.2 million in Q2 2025.
Analysis
Siga Technologies (SIGA) Net Cash Flow (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Net Cash Flow for 16 consecutive years, with -$10.5 million the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Net Cash Flow fell 36.82% year-over-year to -$10.5 million; the trailing twelve-month figure through Sep 2025 stood at $72.7 million (up 158.16% YoY), and the FY2024 full-year result was $5.3 million, down 89.77% from the prior year.
- Net Cash Flow slipped to -$10.5 million in Q3 2025 per SIGA's latest filing, from $20.2 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$39.5 million in Q2 2023.
- Historically, Net Cash Flow has averaged $2.8 million across 5 years, with a median of -$5.7 million in 2021.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow tumbled 381.62% in 2022, then soared 821.16% in 2023.
- Over 5 years, Net Cash Flow stood at $10.3 million in 2021, then sank by 206.2% to -$11.0 million in 2022, then jumped by 821.16% to $79.0 million in 2023, then retreated by 28.98% to $56.1 million in 2024, then tumbled by 118.72% to -$10.5 million in 2025.
- According to Business Quant data, Net Cash Flow over the past three periods registered -$10.5 million, $20.2 million, and $6.9 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn | -1.27 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn | -2.82 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | 1.53 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn | 757.00 Mn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -722.00 Mn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn | 918.27 Mn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - | 374.50 Mn |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn | 521.33 Mn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn | 523.50 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -10.51 Mn |
| Jun 30, 2025 | 20.19 Mn |
| Mar 31, 2025 | 6.87 Mn |
| Dec 31, 2024 | 56.13 Mn |
| Sep 30, 2024 | -7.68 Mn |
| Jun 30, 2024 | -36.92 Mn |
| Mar 31, 2024 | -6.28 Mn |
| Dec 31, 2023 | 79.03 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -39.47 Mn |
| Mar 31, 2023 | 16.89 Mn |
| Dec 31, 2022 | -10.96 Mn |
| Sep 30, 2022 | -4.78 Mn |
| Jun 30, 2022 | -38.73 Mn |
| Mar 31, 2022 | 50.12 Mn |
| Dec 31, 2021 | 10.32 Mn |
| Sep 30, 2021 | -5.67 Mn |
| Jun 30, 2021 | -8.04 Mn |
| Mar 31, 2021 | -11.36 Mn |
| Dec 31, 2020 | 39.23 Mn |